Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-acting propranolol in essential tremor.

W C Koller

    Neurology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Long-acting propranolol (propranolol-LA) offers a convenient and effective treatment for essential tremor, with most patients preferring it for ease of use and tremor reduction compared to divided doses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

    European journal of neurology·2009
    Same author

    A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

    Parkinsonism & related disorders·2008
    Same author

    Topiramate in essential tremor: a double-blind, placebo-controlled trial.

    Neurology·2006
    Same author

    Apolipoprotein E controls the risk and age at onset of Parkinson disease.

    Neurology·2004
    Same author

    Advances in the treatment of Parkinson's disease.

    Drugs of today (Barcelona, Spain : 1998)·2004
    Same author

    Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

    Neurology·2003

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Essential tremor is a common neurological disorder.
    • Current treatments include medications with varying efficacy and side effect profiles.

    Purpose of the Study:

    • To compare the efficacy and patient preference of long-acting propranolol (propranolol-LA) versus traditional divided-dose propranolol in managing essential tremor.

    Main Methods:

    • A study involving 18 patients with essential tremor.
    • Comparison of propranolol-LA with propranolol administered in divided doses.
    • Assessment of patient preference for ease of administration and tremor control.
    • Objective measurement of tremor amplitude reduction.

    Main Results:

    • 87% of patients preferred propranolol-LA for its ease of administration.

    Related Experiment Videos

  • 67% of patients favored propranolol-LA for better tremor control.
  • Propranolol-LA demonstrated similar or greater tremor amplitude reduction compared to divided dosing in most patients.
  • Three patients showed no response to either propranolol formulation.

    • Conclusions:

    • Long-acting propranolol (propranolol-LA) is a well-tolerated and effective option for essential tremor management.
    • Patient preference for propranolol-LA highlights its practical advantages in daily use.
    • Propranolol-LA represents a valuable therapeutic advancement for individuals suffering from essential tremor.